Seven tumors had BRAF mutation (one was a rare mutation: BRAFp.G469A), six had BRAF fusion, and two were empirically treated; one (#10) had NF1 and one (#14) with DLGNT had small tumor biopsy insufficient for NGS testing. The gene discussed is BRAF; the disease is neoplasm.